Multi-Use Pharma Logistics
Relevance
As pharmaceutical supply chains expand through the growth of biologics, vaccines, and advanced therapies, reusable packaging systems and transport assets are becoming increasingly important. However, limited visibility into how these assets circulate across the cold chain, combined with fragmented circular practices and inconsistent emissions reporting, makes it difficult to fully capture their sustainability impact. Addressing these gaps is essential to improving Scope 3 transparency and supporting more sustainable, evidence-based decision-making.
GOAL
Project Objectives
- Objective 1: Circularity Mapping, Evidence & Gap Analysis (WP1)
Establish a baseline understanding of packaging and transport assets across the circular economy spectrum, and identify existing gaps.
- Objective 2: Circular Flow Mapping & Emissions Accounting (WP2)
Develop structured and parameterised models of packaging and asset circulation flows supporting transparent accounting aligned with ISO 14083 and GLEC principles.
- Objective 3: Circular System Performance & Optimisation Analysis (WP3)
Evaluate the operational, environmental, and economic performance of current circular packaging and asset management systems and identify opportunities for improvement.
- Objective 4: Framework Development & Validation for Packaging & Asset Circularity (WP4)
Develop and validate an industry-aligned framework that integrates circular economy principles, emissions accounting methodologies, operational guidance, stakeholder responsibilities, and best practice.
- Objective 5: Industry Guidance, Recommendations & Implementation Roadmap (WP5)
Consolidate project findings into practical guidance, recommendations, and implementation pathways.
Timeline
JUNE - SEP
Circularity Mapping, Evidence & Gap Analysis
AUG - OCT
SEP - NOV
OCT - DEC
DEC - FEB 2027
Circular Flow Mapping & Emissions Accounting
Circular System Performance & Optimisation Analysis
Framework Development & Validation for Packaging & Asset Circularity
Industry Guidance, Recommendations & Implementation Roadmap
PROJECT
SUPPORT AND
COLLABORATION.
Pharma.Aero & Smart Freight Center
Pharma.Aero
- Board Liaison: Liew Zhong Yao (Changi Airport Group)
- Project Leads: Ruud van der Geer (MSD), Gergely Szorcsik (Zoetis)
- Internal Strategic Expert: Frank Van Gelder, Pharma.Aero
- Project Expert (External): Céline Crahay – 3CeL Consulting
- Project Manager: Sara Van Lerberghe
Smart Freight Center
- Andrea Dorothea Schoen, Julie Branche-Chucri, Gabriel von Müller
- Michael Hegglin – SkyCell AG
Florence Lehec – EMBALL’ISO
Sreedevi Rajagopalan - Linus Wollentz – Envirotainer
Pernilla Sörme – My Green Lab
Patricia F. Varela – International Air Transport Association (IATA)
